Expert panel recommendation: but with logistical problems with mRNA vaccines, there is nothing to prevent use of Astra-Zeneca vaccine in people 65 plus.
The 18 members of the National Immunization Panel at the Department of Health and Human Services unanimously recommend use of the Astra-Zeneca vaccine in the 18- to 64-year-old age group. “There are sufficient good safety and effectiveness data for this age group to recommend the vaccine as having good efficacy against symptomatic infection and severe morbidity (hospitalization, intensification, death) for 18- to 64-year-olds,” according to the preamble to the recommendation, which was released late Sunday night.
For people 65 plus, the mRNA vaccines (from Biontech/Pfizer and Moderna) should be preferred. However, “In the event of logistical problems in vaccine use with the mRNA vaccines, there is nothing to prevent use of the Astra-Zeneca vaccine in persons 65+,” the recommendation states.
- source: kurier.at/picture: pixabay.com
This post has already been read 140 times!